Platelet function testing: Quality assurance

被引:46
作者
Hayward, Catherine P. M.
Eikelboom, John
机构
[1] McMaster Univ, Med Ctr, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[3] Hamilton Hlth Sci Corp, Hamilton Reg Lab Med Program, Hamilton, ON, Canada
[4] St Josephs Healthcare, Hamilton, ON, Canada
[5] McMaster Univ, Dept Med, Hamilton, ON, Canada
[6] Hamilton Gen Hosp, Thrombosis Serv, Hamilton Hlth Sci Corp, Hamilton, ON, Canada
关键词
platelet function testing; quality assurance; platelet disorders; platelet aggregation; platelet secretion; Platelet Function Analyzer-100 closure time; bleeding time;
D O I
10.1055/s-2007-971814
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelet function tests are widely used for the diagnosis of platelet disorders. In recent years there has been increasing interest in the use of platelet function tests to monitor antiplatelet drug therapy. Quality assurance is important to optimize the performance of laboratory assays but it has not been widely applied to platelet function tests. This deficiency likely reflects the need to use freshly collected blood samples for platelet function tests, and the complex, time-consuming nature of some assays such as aggregation studies. Platelet function testing lacks guidelines, is poorly standardized between laboratories, and rarely is evaluated by internal and external quality assurance exercises. The sensitivity, specificity, and diagnostic utility of some newer, simplified assays of platelet function have been evaluated in a range of clinical settings but corresponding quality assurance data for many established as well as emerging platelet function assays are lacking. Quality assurance issues relevant to testing platelet function are reviewed in this article, with a focus on their application to established and to new and emerging tests.
引用
收藏
页码:273 / 282
页数:10
相关论文
共 67 条
[1]   Quantifying the effect of antiplatelet therapy -: A comparison of the platelet function Analyzer (PFA-100®) and modified thromboelastography (mTEG®) with lightt transmission platelet aggregometry [J].
Agarwal, Seema ;
Coakely, Margaret ;
Reddy, Kalpana ;
Riddell, Anne ;
Mallett, Susan .
ANESTHESIOLOGY, 2006, 105 (04) :676-683
[2]  
Bailey Lori A, 2005, J Extra Corpor Technol, V37, P43
[3]   THE BLEEDING-TIME AS A PREOPERATIVE SCREENING-TEST [J].
BARBER, A ;
GREEN, D ;
GALLUZZO, T ;
TSAO, CH .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (05) :761-764
[4]   Influence of platelet count and activity on thromboelastography parameters [J].
Bowbrick, VA ;
Mikhailidis, DP ;
Stansby, G .
PLATELETS, 2003, 14 (04) :219-224
[5]   Can platelet aggregometry be standardized? [J].
Breddin, HK .
PLATELETS, 2005, 16 (3-4) :151-158
[6]  
BURGESSWILSON ME, 1987, BLOOD, V69, P38
[7]   Antiplatelet drug resistance: Not ready for prime time [J].
Burns, TL ;
Mooss, AN ;
Hilleman, DE .
PHARMACOTHERAPY, 2005, 25 (11) :1621-1628
[8]  
Clark G B, 1990, Clin Lab Manage Rev, V4, P7
[9]   Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus [J].
Coiffic, A ;
Cazes, E ;
Janvier, G ;
Forestier, F ;
Lanza, F ;
Nurden, A ;
Nurden, P .
THROMBOSIS RESEARCH, 1999, 95 (02) :83-91
[10]   Comparison of modified thrombelastograph and plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients [J].
Craft, RM ;
Chavez, JJ ;
Snider, CC ;
Muenchen, RA ;
Carroll, RC .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2005, 145 (06) :309-315